Close
Nordic 9Nordic 9

SPRIM Global Investments (investor - Others)

Singapore
See something wrong or missing? Let us know
Offices:Singapore
Average round investment:24.58M USD
Average number per year:1.5
Distribution: 2025 (2)2024 (1)
Portfolio companies: France Lattice MedicalBelgium Azalea VisionSwitzerland Stalicla
Mostly invests in: France France (1) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SPRIM Global Investments

Name Criteria
Germany 415 Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Austria Hil-Invent GmbH
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
China China Grand Pharmaceutical and Healthcare Holdings
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Biocodex
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Global Emerging Markets
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States What If Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Canada CTI Life Sciences
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France OCCTE
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Belgium, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top